Chinook Therapeutics, Inc. (NASDAQ:KDNY – Get Rating) – Stock analysts at HC Wainwright upped their FY2027 earnings per share (EPS) estimates for shares of Chinook Therapeutics in a research report issued to clients and investors on Wednesday, May 10th. HC Wainwright analyst E. Arce now forecasts that the company will post earnings per share of […]